MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fendo.2025.1691509

Медицинская библиотека · Frontiers in endocrinology · 2025

Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature.

Zhong Xueyu, Chen Yang, Liu Geng, Cui Zhenhai, Luo Kuanhong, Wu Zhixin, Xiao Kangli, Li Huiqing

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study analyzed metabolic indicators and height gain in short-statured children within the first year of recombinant human growth hormone (rhGH) therapy, identifying predictive factors for treatment efficacy.

METHODS

A retrospective analysis of 72 children with short stature (growth hormone deficiency or idiopathic short stature) receiving rhGH therapy (January 2022 to January 2024) was performed. Data included height, weight, age, skeletal age (SA), and laboratory results (IGF1, fasting glucose, insulin, C-peptide, thyroid function, lipids). Analyses focused on height standard deviation score (HSDS), HSDS for SA, and factors associated with 12-month changes in HSDS for SA (△HSDS for SA).

RESULTS

The mean initial rhGH dose was 0.053 ± 0.010mg/kg/day, with a mean starting age of 8.36 ± 2.24 years. Significant increases in HSDS and HSDS for SA were observed after 12 months. △HSDS for SA negatively correlated with baseline homeostasis model assessment of insulin resistance (HOMA-IR) and fasting insulin, and positively correlated with baseline free triiodothyronine (FT3). Children with △HSDS for SA>0.5 had lower baseline insulin and HOMA-IR, and higher FT3, high-density lipoprotein cholesterol (HDL), and hemoglobin.

CONCLUSIONS

Insulin resistance, hyperinsulinemia, FT3, and HDL determine rhGH efficacy in short-statured children. Metabolic profiling optimizes rhGH therapy, and targeting insulin resistance may improve growth outcomes.

Для цитирования: Zhong Xueyu, Chen Yang, Liu Geng, Cui Zhenhai, Luo Kuanhong, Wu Zhixin, Xiao Kangli, Li Huiqing. Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature.. Frontiers in endocrinology. 2025. DOI: 10.3389/fendo.2025.1691509.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.